Another overdose reversal drug reaches the market : vimarsan

Opvee is an inhaled version of nalmefene, a drug approved nearly 30 years ago in injectable and oral forms to reverse opioid overdoses.

Related Keywords

Ireland , Miami , Florida , United States , Maine , Washington , Robert Califf , Megan Messerly , Suzanne Schwartz , Erica Jefferson , David Lim , Brian King , Katherine Ellen Foley , Tammy Beckham , Jerome Adams , Lauren Sausser , Rose Lundy , Heidi Rebello , Nabarun Dasgupta , Charlene Le Fauve , Martin Valdes , Ben Leonard , Affairs On , Office Of The Center Director , Miami Herald , Tellus Clinical Research , Health News , Technology Innovation , National Institutes Of Health , Schwartz , Shortages Prevention Program , Chapel Hill University , Health Affairs , Office Of Strategic Partnerships , Office Of External Affair , Udall Foundation , Hill University , Reagan Udall Foundation , Tobacco Products , National Institutes , E Cigarette Summit , Strategic Partnerships , Resilient Supply Chain , External Affairs , External Affair ,